- About Us
- News & Events
- Get Information
- Our Research
- Treatment Trials
Professor Jayashri Kulkarni
Professor Jayashri Kulkarni
MBBS, MPM, FRANZCP, PhD
Jayashri Kulkarni commenced her appointment as Professor of Psychiatry, The Alfred and Monash University in 2002. She directs a large psychiatric research group, the Monash Alfred Psychiatry Research Centre (MAPrc), which has a team of over 100 staff and post-graduate students from medicine, nursing, psychology, allied health, science, and health information services. Funding for this group comes from a number of national and international project grants plus industry collaboration.
Jayashri Kulkarni is a Monash University Medical School graduate and was an Alfred Hospital medical student. She became a Fellow of the Royal Australian and New Zealand College of Psychiatrists in 1989.
Jayashri Kulkarni was appointed as the first Associate Professor/Director of Psychiatry to Dandenong Hospital, Department of Psychiatry in 1994. She founded and directed the Dandenong Psychiatry Research Centre (DPRC) and the Monash University Research Centre for Women's Mental Health.
Jayashri Kulkarni was the Director of Psychiatry of Dandenong Area Mental Health Service (DAMHS) for eight years.
Research undertaken by Professor Kulkarni commenced in 1988, and then expanded upon founding the Research Centre at Dandenong. She was awarded a PhD from Monash University in 1997 for her thesis titled "Women and Psychosis". A major area of her research involved psychoneuroendocrine studies of the hypothalamic-pituitary-gonadal axis in women with schizophrenia. She has also conducted many other studies in the area of gender differences in schizophrenia. Recently, several studies using estrogen as a treatment for women with schizophrenia have been conducted and the results have received considerable national and international attention from 1998 onwards.
Jayashri Kulkarni has conducted clinical studies in schizophrenia including Prolactin and growth hormone challenge tests, atrial natriuretic peptide changes, rapid/slow eye movement changes, platelet dopamine uptake studies, a dopamine infusion study in Parkinson's Disease, a validation study of DSM IV Psychotic Disorders Criteria, several studies in the area of first episode psychosis including the development of a community-based approach to the treatment of early psychosis studies in cannabis and psychosis and recently a three year follow up quality of life and health economics study of 300 patients with schizophrenia. Other research projects are being conducted in electrophysiology of schizophrenia with EEG and Transcranial Magnetic Stimulation. Several studies in the area of cannabis and psychosis are also being conducted.
Professor Kulkarni has presented her research at many international and national conferences. She was invited in 1998 to speak on her work at the Institute for Mental Health Research in Mannheim, Germany and has also been a keynote speaker at Schizophrenia Conferences in Davos (Switzerland), Stockholm, USA, UK, New Zealand and throughout Australia. Jayashri received a Travelling Research Scholarship in 1997 from Janssen Cilag and the Australasian Psychiatry Research Organon Research prize in 1995. She has co-edited a book on "Women and Schizophrenia" for Cambridge University Press and has written two chapters in a book on "The Recognition and Management of Schizophrenia" - Cambridge University Press. Jayashri was the Deputy Chairperson for the Victorian Ministerial Advisory Committee on Mental Health, and is currently a Member of the Forensic Leave Panel, and is on the Psychosurgery Review Board, the advisory boards of the pharmaceutical companies Janssen Cilag and Pfizer, and the Ministerial Expert Committee on Cannabis and Psychosis. Jayashri was a finalist in the Telstra Business Women's Awards in 2001.
Professor Kulkarni has received multiple grants during her research career. These have included National Health & Medical Research Council (NH&MRC) project grants, Eli Lilly, Janssen Cilag, and Bristol Myer Squibb investigator initiated research grants, funding from the Stanley Foundation (Washington), NARSAD (New York) and several Victorian Government Health & Human Services innovative practice grants.